Salarius Pharmaceuticals Inc. buy melinda
Start price
15.04.17
/
50%
€49,892
Target price
27.04.17
€57,784
Performance (%)
9.04%
End price
27.04.17
€54,402
Summary
This prediction ended on 27.04.17 with a price of €54,402. With a performance of 9.04%, the BUY prediction by melinda for Salarius Pharmaceuticals Inc. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Salarius Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % | 49,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % | 82,05 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % | 60,62 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % | 59,66 % |
Comments by melinda for this prediction
In the thread Flex Pharma Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
hat $
Stopped prediction by melinda for Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€51,442
12.06.17
12.06.17
€57,784
21.06.17
21.06.17
14.25%
21.06.17
21.06.17
